Tiziana Life Sciences Ltd. (TLSA)
Nasdaq: TLSA · Pharmaceutical Preparations · London, England, GB · filing with the SEC since 2017
Who owns Tiziana Life Sciences Ltd.
As filed with the SECHolders of 5% or more
2
Laura Natalia Monica Fonda holds 5.7% of Common, as its SCHEDULE 13G filed Oct 28, 2025 says.
Directors and officers
3
report now, of 3 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Laura Natalia Monica Fonda
SCHEDULE 13G · filed Oct 28, 2025 · Common
Chernett Jorey
SCHEDULE 13G/A · filed Dec 10, 2025 · Common · 6.1% in Nov 14, 2025
What TLSA reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 3 countries, from the list filed with the 20-F filed May 1, 2026.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$1.0Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 3 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Elrifi Ivor | Chief Executive Officer | 0 | $0 | 0 | 3 | $1.0M |
| Cerrone Gabriele M | director | 0 | $0 | 0 | 2 | $100,000 |